BIOPHARM INSIGHT
DEAD

Serial Number

86315630

Owner

Mergermarket Limited

Attorney

Thomas J. Donovan

Filing Date

Jun 20, 2014

Add to watchlist:

No watchlists yet
View on USPTO

BIOPHARM INSIGHT Trademark

Serial Number: 86315630

BIOPHARM INSIGHT is a trademark filed by Mergermarket Limited on June 20, 2014. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Mergermarket Limited (24 trademarks)

80 Strand
London WC2ORL , GB

Entity Type: 99

Trademark Details

Filing Date

June 20, 2014

Registration Date

Not Registered

Published for Opposition

October 20, 2015

Goods & Services

Education services, namely, providing of training in the fields of business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; arranging and conducting seminars in the fields of business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; library services provided by means of a computer database which feature on-line newspapers, magazines, photographs and pictures via an on-line computer network; publication of reports, books and newsletters in the field of financial information, financial reports and financial analysis

Electronic publications, namely, reports, books and newsletters in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning recorded on computer media; digital media and recordings, namely, pre-recorded DVDs, downloadable audio and video recordings, and CDs in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; electronic books in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning recorded on computer media; downloadable electronic publications in the nature of reports, books and newsletters in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; downloadable digital media and recordings namely, electronic video recordings in the fields of biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; Downloadable electronic data files featuring data in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; computer software for desktop publishing

Financial advice and consultancy services; financial research, analysis, forecasting and advisory services; financial information; financial information relating to mergers, acquisitions, corporate transactions, debt finance, debt trading and debt issuance; debt collection services; financial information evaluation, appraisal, forecasting and reporting; financial analysis; financial research services; financial information and financial advisory services; financial advice and consultancy services provided online via the Internet, telecommunication and other electronic communication networks; financial research, analysis, forecasting and advisory services provided online via the Internet, telecommunication and other electronic communication networks; financial information provided online via the Internet, telecommunication and other electronic communication networks; financial information relating to mergers, acquisitions, corporate transactions, debt finance, debt trading and debt issuance provided online via the Internet, telecommunication and other electronic communication networks; debt collection services provided online via the Internet, telecommunication and other electronic communication networks; financial information evaluation, appraisal, forecasting and reporting provided online via the Internet, telecommunication and other electronic communication networks; financial analysis provided online via the Internet, telecommunication and other electronic communication networks; financial research services provided online via the Internet, telecommunication and other electronic communication networks; financial information and financial advisory services provided online via the Internet, telecommunication and other electronic communication networks; providing information and news in the fields of corporate financial transactions, debt finance, debt trading, debt issuance, investment advice on biotechnology drugs, investment advice on biotechnology medical products, investment advice on biotherapeutics and investment advice on biologicals and related research and development companies, investment strategies for high net worth individuals, and financial retirement planning; providing financial information and financial news relating to business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs industry, biotechnology medical products industry, biotherapeutics industry, and biologicals and related research and development industries, investment strategies for high net worth individuals, and retirement planning

Advertising services; business management; business administration services and managing office functions in the nature database management for others; business information management services; business consultancy services; business management and organisation consultancy services; provision of business and commercial information for the academic and scientific, and professional and business communities in the fields of biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; business research services; commercial information agency services; provision of statistical information for business and commercial purposes in the field of business investments, mergers and acquisitions; conducting public opinion polling services; conducting market opinion polling studies; compilation and systemisation of information into computer databases; computerised file managing; document reproduction; arranging newspapers and magazine subscriptions for others; news clipping services; publication of publicity texts; marketing research and marketing research studies; arranging and conducting exhibitions, conferences, congresses, conventions and trade shows for business and commercial purposes; data retrieval services, namely, providing an on-line searchable database featuring business information and commercial information; business information and advisory services; research and analysis in the fields of economics; providing business information and business news relating to business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs industry, biotechnology medical products industry, biotherapeutics industry, and biologicals and related research and development industries; preparing financial reports for others; preparing financial reports for others via the Internet, telecommunication and other electronic communication networks; providing information and news in the fields of mergers and acquisitions of corporations

Providing scientific information and related research and development information in the fields of biotechnology drugs, biotechnology medical products, biotherapeutics, and biologicals

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jan 16, 2018 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 15, 2018 ABN6
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 4, 2017 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 4, 2017 COAR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 4, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 4, 2017 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 17, 2017 EXRA
SOU EXTENSION 3 GRANTED
Jun 15, 2017 EX3G
SOU EXTENSION 3 FILED
Jun 15, 2017 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 15, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 17, 2016 EXRA
SOU EXTENSION 2 GRANTED
Dec 15, 2016 EX2G
SOU EXTENSION 2 FILED
Dec 15, 2016 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 15, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 22, 2016 EXRA
SOU EXTENSION 1 GRANTED
Jul 21, 2016 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 20, 2016 AITU
SOU EXTENSION 1 FILED
Jun 14, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 14, 2016 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 15, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 20, 2015 NPUB
PUBLISHED FOR OPPOSITION
Oct 20, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 30, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 14, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 8, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 11, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 10, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 10, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 22, 2015 GNRN
NON-FINAL ACTION E-MAILED
May 22, 2015 GNRT
NON-FINAL ACTION WRITTEN
May 22, 2015 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 8, 2015 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 5, 2015 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 17, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 15, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 31, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 31, 2015 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 31, 2015 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 3, 2015 GNFN
FINAL REFUSAL E-MAILED
Feb 3, 2015 GNFR
FINAL REFUSAL WRITTEN
Feb 3, 2015 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 30, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 30, 2014 CRFA
ASSIGNED TO LIE
Dec 30, 2014 ALIE
ASSIGNED TO LIE
Dec 17, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 9, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 9, 2014 GNRN
NON-FINAL ACTION E-MAILED
Oct 9, 2014 GNRT
NON-FINAL ACTION WRITTEN
Oct 9, 2014 CNRT
ASSIGNED TO EXAMINER
Sep 29, 2014 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 28, 2014 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 27, 2014 NWOS
NEW APPLICATION ENTERED
Jun 24, 2014 NWAP